Literature DB >> 30273713

Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges.

Esmond Lee1, Jaichandran Sivalingam2, Zhong Ri Lim3, Gloryn Chia3, Low Gin Shi4, Mackenna Roberts5, Yuin-Han Loh6, Shaul Reuveny3, Steve Kah-Weng Oh3.   

Abstract

In vitro generation of red blood cells (RBCs) has the potential to circumvent the shortfalls in global demand for blood for transfusion applications. The conventional approach for RBC generation has been from differentiation of hematopoietic stem cells (HSCs) derived from cord blood, adult bone marrow or peripheral blood. More recently, RBCs have been generated from human induced pluripotent stem cells (hiPSCs) as well as from immortalized adult erythroid progenitors. In this review, we highlight the recent advances to RBC generation from these different approaches and discuss the challenges and new strategies that can potentially make large-scale in vitro generation of RBCs a feasible approach.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cord blood; Erythroid; Hematopoietic; Immortalized; Induced pluripotent stem cells; Red blood cells

Mesh:

Year:  2018        PMID: 30273713     DOI: 10.1016/j.biotechadv.2018.09.006

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  8 in total

1.  Sequential cellular niches control the generation of enucleated erythrocytes from human pluripotent stem cells.

Authors:  Jun Shen; Yaoyao Zhu; Cuicui Lyu; Zicen Feng; Shuzhen Lyu; Yuping Zhao; Dixie L Hoyle; Guangzhen Ji; Weimin Miao; Xiaobing Zhang; Linzhao Cheng; Robert A Brodsky; Tao Cheng; Zack Z Wang
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

2.  Single-cell transcriptomic analysis identifies an immune-prone population in erythroid precursors during human ontogenesis.

Authors:  Changlu Xu; Jian He; Hongtao Wang; Yingnan Zhang; Jing Wu; Lu Zhao; Yue Li; Jie Gao; Guangfeng Geng; Bingrui Wang; Xiaoyuan Chen; Zhaofeng Zheng; Biao Shen; Yang Zeng; Zhijie Bai; Hua Yang; Shujuan Shi; Fang Dong; Shihui Ma; Erlie Jiang; Tao Cheng; Yu Lan; Jiaxi Zhou; Bing Liu; Lihong Shi
Journal:  Nat Immunol       Date:  2022-06-27       Impact factor: 31.250

3.  Transforming growth factor β1 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy.

Authors:  Rutuja Kuhikar; Nikhat Khan; Joseph Philip; Sameer Melinkeri; Vaijayanti Kale; Lalita Limaye
Journal:  Stem Cell Res Ther       Date:  2020-02-19       Impact factor: 6.832

4.  BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.

Authors:  Senquan Liu; Mengyao Wu; Moira Lancelot; Jiusheng Deng; Yongxing Gao; John D Roback; Tong Chen; Linzhao Cheng
Journal:  Mol Ther       Date:  2021-01-21       Impact factor: 11.454

5.  Erythroid Differentiation of Induced Pluripotent Stem Cells Co-cultured with OP9 Cells for Diagnostic Purposes.

Authors:  Juhye Roh; Sinyoung Kim; June-Won Cheong; Su-Hee Jeon; Hyun-Kyung Kim; Moon Jung Kim; Hyun Ok Kim
Journal:  Ann Lab Med       Date:  2022-07-01       Impact factor: 4.941

6.  Membrane Properties of Human Induced Pluripotent Stem Cell-Derived Cultured Red Blood Cells.

Authors:  Claudia Bernecker; Eva Maria Matzhold; Dagmar Kolb; Afrim Avdili; Lisa Rohrhofer; Annika Lampl; Martin Trötzmüller; Heike Singer; Johannes Oldenburg; Peter Schlenke; Isabel Dorn
Journal:  Cells       Date:  2022-08-09       Impact factor: 7.666

7.  In Vitro Generation of Red Blood Cells from Stem Cell and Targeted Therapy.

Authors:  Ping Zhou; Mouna Ouchari; Yun Xue; Qinan Yin
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 8.  Therapeutic use of red blood cells and platelets derived from human cord blood stem cells.

Authors:  Xiaoyan Xie; Hailei Yao; Xiaoyan Han; Wen Yue; Xuetao Pei
Journal:  Stem Cells Transl Med       Date:  2021-11       Impact factor: 6.940

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.